−£128k
vs Apr 2024Active13310067Private limited companyWoodford Green
SIBACHI RESEARCH LTD
Significant control: Bala Sekhar Reddy Sirigireddy (75–100%)
From public filings as at 31 Aug 2026; may contain errors or be out of date. Verify at Companies House · Terms
Watch this company
Get an email when Companies House records a change for Sibachi Research Ltd: status, filings, accounts, officers or owners. Free.
Not live yet: alerts start by 15 December 2026. We store your email and this company number only, for these alerts. If alerts don’t launch, we tell you and delete your address. Privacy
Coming soon · product and service lists
What does Sibachi Research Ltd sell?
Registered activity: Research and experimental development on biotechnology (SIC 72110). We’re building product and service lists for UK companies. Get this one when it’s ready.
One email, only about this. If we don’t launch within 60 days we’ll tell you. Privacy
01
Summary
SIBACHI RESEARCH LTD is an active private limited company (company number 13310067) incorporated on 1 April 2021, registered in Woodford Green. Its registered activity is research and experimental development on biotechnology (SIC 72110). Latest abridged accounts cover the period ending 30 April 2025, showing net assets of −£128k and cash of £6,811, with 0 employees on average. As abridged accounts, no profit and loss account is filed, so turnover and profit are not public. Net assets fell 47% on the prior period (−£87k).
Peer position · net assets
By net assets it sits in the bottom quarter of 151 comparable companies in Greater London (median £200, upper quartile £53k).
02
Ownership and control
- Mr Bala Sekhar Reddy Sirigireddy
- owns 75–100% of shares
- holds 75–100% of voting rights
- can appoint or remove directors
Persons with significant control hold 25% or more of shares or voting rights. Smaller shareholdings are only listed in confirmation-statement documents. Directors and secretaries: see the officers list at Companies House.
03
Key dates
- Incorporated
- 1 April 20215 yrs ago
- Next accounts due
- 30 January 2027in 97 days
- Confirmation statement due
- 15 April 2027in 172 days
Due dates are expected from Companies House filing rules; confirm on the official register before relying on them.
04
Activity
- SIC 72110
- Research and experimental development on biotechnology
- SIC 74909
- Other professional, scientific and technical activities n.e.c.
- Accounts type
- Unaudited Abridged
- Size band
- MicroCompanies Act thresholds
05
Financials
£6,811
−31%vs Apr 2024Not disclosed
0
vs Apr 2024| Period end | Net assets | Cash | Debtors | Creditors <1y | Turnover | Profit | Employees |
|---|---|---|---|---|---|---|---|
| 30 April 2025 | −£128k | £6,811 | — | — | — | — | 0 |
| 30 April 2024 | −£87k | £9,927 | — | — | — | — | 0 |
Figures as filed in iXBRL accounts at Companies House. "—" means the line was not reported in that filing.
06
Filing and accounts signals
- Net assets below zeroNet assets £-128,116 at 30 April 2025
- Net assets down 25% or more on the prior period-46.9% vs prior period
- Incorporated five or more years agoIncorporated 1 April 2021
Neutral facts read from the register and filed accounts, each with its evidence. They are not a rating, a prediction or advice, and may be incomplete or out of date. How each signal is derived.
07
Timeline
- Confirmation statement duein 172 days
- Next accounts duein 97 days
- Accounts period endNet liabilities £128k · abridged accounts
- Accounts period endNet liabilities £87k · abridged accounts
- Incorporated
08
Similar companies in Greater London
- LOVEMAMI MEDICAL CENTERBeckenham · inc. Apr 2021
- OCANT BIOLOGICAL TECHNOLOGY CO., LTD.Beckenham · inc. Mar 2021
- INOVAPHARM LIMITEDKingston Upon Thames · inc. Feb 2021
- GLYCOS BIOMEDICAL LTDWalton-On-Thames · inc. May 2021
- ALLOSTERICA LIMITEDLeatherhead · inc. May 2021
- OCULAR INTERFACE LIMITEDOrpington · inc. Feb 2021
All companies incorporated on 1 April 2021 · in Apr 2021.
09
Reminders for SIBACHI RESEARCH LTD
Get an email before each filing deadline — accounts and confirmation statement — so nothing is late.